RY公司融资策略研究
发布时间:2018-05-01 12:22
本文选题:融资 + 融资策略 ; 参考:《广西师范大学》2014年硕士论文
【摘要】:我国是原料药生产大国,却不是生产强国。我国的原料药多属低端原料药。要提高我国原料药产业的国际竞争力,必然要进军中高端原料药市场。以RY公司为代表的科技型中小原料药企业,能否募集到足够的投产资金,将工艺技术转化为现实的生产能力,直接关系着我国整个原料药行业能否成功转型。 RY公司经过八年的探索和积累,已成功掌握了多种特色抗肿瘤原料药及中间体产品的规模化生产工艺。为了进一步拓展国际原料药市场,其首要解决的是筹措建设资金的问题。然而,RY公司同其他中小科技型企业一样,面对成熟的生产工艺和广阔的销售市场,却因缺乏清晰明确的融资策略,难以获得所需的投产资金。 为解决RY公司的融资难题,本文从RY公司的融资环境和自身财务状况入手,详尽分析了RY公司的财务状况和预期投资收益;通过对公司运营资金的需求量和建设资金的需求量的量化分析,确定了公司的融资规模;最后,通过构建融资评价模型,制定出以内部融资方案和权益融资方案为主,以债务融资方案为补充的科学有效的融资方案。 通过对RY公司融资策略的应用研究,很好的解决了RY公司的融资难题,对于类似的科技型中小原料药企业制定相关的融资策略具有参考价值。
[Abstract]:Our country is big country of raw material medicine production, but not strong country of production. Most of the raw materials in China belong to low end raw materials. In order to improve the international competitiveness of China's API industry, it is necessary to enter the mid-high-end API market. Whether the small and medium sized raw material pharmaceutical enterprises, represented by ry Company, can raise enough funds to turn the process technology into actual production capacity is directly related to the successful transformation of the whole raw material medicine industry in China. After eight years of exploration and accumulation, ry has successfully mastered the large-scale production process of various characteristic antitumor raw materials and intermediates. In order to further expand the international API market, its primary solution is to raise construction funds. However, in the face of mature production technology and broad sales market, the company, like other small and medium-sized technological enterprises, is difficult to obtain the necessary fund for production because of the lack of clear financing strategy. In order to solve the financing problem of ry Company, this paper starts with the financing environment and its own financial situation of ry Company, and analyzes the financial situation and expected investment income of ry Company in detail. Through the quantitative analysis of the demand for operating funds and construction funds, the financing scale of the company is determined. Finally, the internal financing scheme and the equity financing scheme are established through the construction of the financing evaluation model. A scientific and effective financing scheme supplemented by a debt financing scheme. Through the research on the application of financing strategy of ry company, it solves the financing problem of ry company well, and has reference value for similar small and medium-sized pharmaceutical enterprises of science and technology type to formulate the related financing strategy.
【学位授予单位】:广西师范大学
【学位级别】:硕士
【学位授予年份】:2014
【分类号】:F406.7;F426.72
【参考文献】
相关期刊论文 前9条
1 陈珏宇;叶静雅;;现代企业资本结构理论研究及其发展[J];广西大学学报(哲学社会科学版);2008年06期
2 束景虹;;融资顺序理论与股权融资偏好研究评述[J];经济学动态;2008年10期
3 徐京生;方巍;;世界医药原料药及中间体行业进展(摘选)[J];精细化工原料及中间体;2003年12期
4 中国人民银行南昌中心支行课题组;潘淦;;金融危机后我国中小企业融资政策述评及国际比较借鉴[J];金融与经济;2013年07期
5 邢燕;陈万江;;中美企业融资顺序差异及我国企业融资偏好原因分析[J];四川经济管理学院学报;2010年01期
6 邓雪;李家铭;曾浩健;陈俊羊;赵俊峰;;层次分析法权重计算方法分析及其应用研究[J];数学的实践与认识;2012年07期
7 王阳;徐怀伏;;中小原料药企核心竞争力评价指标体系研究[J];现代商贸工业;2011年08期
8 胡奕,兰小筠;专利到期药品(美国1998~2012年)分析研究[J];中国药学杂志;2005年05期
9 赵金朋;冯国忠;;我国医药产业研发现状与瓶颈分析[J];现代商贸工业;2012年08期
,本文编号:1829346
本文链接:https://www.wllwen.com/jingjilunwen/kuaiji/1829346.html